![](/img/cover-not-exists.png)
2617 A Prospective Randomized Phase-II Trial with Temsirolimus vs. Sunitinib in non-clear Renal Cell Carcinoma. A Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and Interdisciplinary Renal Cell Carcinoma Group of the German Cancer Society (IAGN)
Bergmann, L., Grünwald, V., Maute, L., Grimm, M.O., Weikert, S., Schleicher, J., Klotz, T., Greiner, J., Westermann, J., Hartmann, A., Moritz, B., Gauler, T.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31435-6
Date:
September, 2015
File:
PDF, 63 KB
english, 2015